Introduction: We investigated the prevalence, predictors of and effect of Antiretroviral
Therapy (ART) regimen on cardiometabolic risk among HIV-positive Ugandan adults at …

The objectives of this study were to determine the epidemiology and correlates of
cardiovascular disease (CVD) risk among Ugandans on first-line antiretroviral therapy …

Background Cardiometabolic diseases are a leading cause of HIV-related morbidity and
mortality, yet routine screening is not undertaken in high-burden countries. We aimed to …

Introduction Cardiovascular disease is one of the leading causes of mortality for people
living with HIV, but limited population‐based data are available from sub‐Saharan Africa …

Objective To compare short-term and long-term cardiovascular disease (CVD) risk scores
and prevalence of metabolic syndrome in HIV-infected adults receiving and not receiving …

Background: Highly active antiretroviral therapy (HAART) has become more accessible to
Human immunodeficiency virus infection/Acquired Immunodeficiency Syndrome (HIV/AIDS) …

Background Cardiovascular disease (CVD) risk among people living with HIV is elevated
due to persistent inflammation, hypertension and diabetes comorbidity, lifestyle factors and …

Background To inform health care and training, resource and research priorities, it is
essential to establish how non-communicable disease risk factors vary by HIV-status in high …

Objectives: Data on cardiovascular disease risks among HIV-infected patients taking
antiretroviral therapy (ART) over long periods of time are lacking in Sub-Saharan Africa …

Background The use of antiretroviral treatment is known to be accompanied by several
negative health outcomes and may negatively affect a country such as South Africa, which is …